相关实验视频
Updated: Jul 6, 2025
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
433
通过改变免疫透,CENPM的升级促进了乳腺癌的发生
Yanchu Tong1, Tongzhou Zhou2, Xiaokun Wang1
1Jingzhou Central Hospital, No. 60 Jingzhong Road, Jingzhou District, Jingzhou City, 434020, Hubei Province, China.
BMC cancer
|January 10, 2024
概括
中心蛋白M (CENPM) 是乳腺癌中的瘤基因,影响患者的治疗结果和免疫透. 在乳腺癌患者中,CENPM可作为预测免疫疗法疗效的生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 众所周知,中间体蛋白M (CENPM) 参与各种癌症,但其在乳腺癌和免疫透中的作用尚不清楚.
- 调查CENPM的影响对于了解乳腺癌进展和治疗策略至关重要.
研究的目的:
- 确定CENPM在乳腺癌中的作用.
- 评估CENPM作为免疫治疗反应的潜在生物标志物.
- 调查CENPM对乳腺癌细胞增殖和迁移的影响.
主要方法:
- 利用TCGA和GEO数据库来分析跨癌症类型的CENPM表达.
- 与乳腺癌患者的预后和临床病理特征相关的CENPM表达.
- 进行了丰富分析,免疫检查点相关性和TIDE算法分析以检测免疫疗法潜力.
- 通过CCK8,殖民地形成,划痕和穿孔测试,评估CENPM对细胞生长和迁移的影响.
主要成果:
- 较高的CENPM水平与较差的患者结果和乳腺癌的特定临床病理特征相关.
- CENPM表达与免疫细胞透的改变有关,包括CD8+ T细胞减少和Tregs增加.
- CENPM与免疫检查点基因的共同表达表明预测治疗反应的潜力.
- 抑制CENPM可以抑制乳腺癌细胞的增殖和迁移.
结论:
- 在乳腺癌中,CENPM充当瘤基因,影响细胞增殖和免疫透.
- 作为预测乳腺癌免疫疗法疗效的生物标志物,CENPM显示出有前途.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
01:46Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K